IPR Matter: Delhi High Court Passes Adverse Order Against Life Technologies Corporation - KPLC 7 News, Lake Charles, Louisiana

IPR Matter: Delhi High Court Passes Adverse Order Against Life Technologies Corporation

  • HealthMore>>

  • FDA to propose e-cigarette regulations

    FDA to propose e-cigarette regulations

    © FDA© FDA
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
  • People seek out health info when famous person dies

    People seek out health info when famous person dies

    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
  • 1 in 13 U.S. schoolkids takes psych meds

    1 in 13 U.S. schoolkids takes psych meds

    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>
    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Life Technologies (India) Pvt. Ltd

NEW DELHI, February 17, 2014 /PRNewswire/ --

?

An application seeking injunction filed by Life Technologies Corporation USA (formerly Invitrogen Corporation) against Life Technologies India Private Limited from using the marks /domains viz. Life Technologies, Life Tech, as well as domains Lifetechindia.com, Lifetechnologiesindia.co.in, LifetechnologiesIndia.Com, Gibcobrlindia.com and Invitrogenindia.com was dismissed by the Hon'ble High Court of Delhi vide its order dated January 29, 2014.

LTIPL, an Indian Company promoted by Mr. Rajan Sahni was established in 2002. Invitrogen Corporation sold out 100% shareholding of its Indian arm ATZ Lab Solutions India Private Limited (ATZ Labs) to LTIPL in December 2002. ATZ Labs (formerly Invitrogen India Pvt. Ltd and Gibcobrl India Pvt. Ltd.) was sold out lock, stock, barrel as a going concern to LTIPL.

Invitrogen Corporation (USA) merged with ABI and changed its name to LTC upon merger in November 2008. After merger it filed two cases in 2010 & 2011 respectively against ATZ Labs before National Arbitration Forum, USA (NAF) for transfer of domains (Gibcobrlindia.com and Invitrogenindia.com) which were dismissed at NAF. After dismissal of the two Petitions at the NAF, LTC then approached LTIPL in Apr 2011 so as to acquire/seek license to use the Intellectual Property of LTIPL namely Life Technologies, Lifetechindia.com, Gibcobrlindia.com, Invitrogenindia.com duly admitting and acknowledging that the above brand names/ related domains were the assets of LTIPL. After being declined by LTIPL, LTC then approached the Hon'ble High Court of Delhi for a prohibitory injunction against LTIPL and ATZ Labs from using the name Life Technologies, Life Tech, Lifetechindia.com, LifetechnologiesIndia.Com, Lifetechindia.co.in, Lifetechnologiesindia.co.in, as well as Gibcobrlindia.com and Invitrogenindia.com.

After nearly 20 months of hearing, the Hon'ble High Court of Delhi has dismissed LTC's application thereby vacating its earlier ex-parte ad-interim injunction. The Hon'ble High Court observed that the litigation commenced only after LTC had lost before NAF for taking another chance to somehow or the other get back the suit marks, domain names etc. from the defendants over which Invitrogen Corporation itself had been left with no rights much before the re-incorporation/resurrection of plaintiff no.1 in the year 2008. The Hon'ble High Court has further held that LTC themselves have accepted the position that the suit trademarks etc. stood vested in ATZ Labs/LTIPL.

Invitrogen Corporation, the US based company that had changed its name to Life Technologies Corporation (LTC) in November 2008 has recently been sold out to Thermo Fisher Scientific Inc., USA on 04 Feb 2014.

ATZ Labs & LTIPL were represented at the NAF and Hon'ble High Court by Mr. Abhishek Saket of Infini Juridique a leading Corporate, IPR and Technology Law Firm in India.

About Life Technologies (India) Pvt. Ltd: an ISO 9001:2008 company that provides products & services to Life Science Research, Industrial Biotech & Bio-Pharma sectors in India and overseas markets to academic, government and corporate entities. The company enjoys an unparalleled goodwill & reputation in the fields of Immunology, Vaccinology, Virology, Tissue Culture, Adjuvant Science, Bioanalyte & Bio-contaminant quantification, over 3000 JAX mice models, Animal Health Monitoring & Screening, Metabolic Research, Next generation Antimicrobials for Laboratory Sanitization & Safety, Biodefense testing, Human Cytogenetics, Phytodiagnostics, Quantitation & Testing tools for DPT, PRP, Hib, Hepatitis B, Meningococcal Pneumonia, Rabies, Polio, MMR, HPV, JEV, Anthrax, Malaria, FMD, Swine Fever etc. The company's vision is to globally provide technologies that make a difference in life science research, so that researchers can reach their goals successfully and sooner, with more value for money.

For more details about this press release:
Contact Mr Rajan Sahni, Managing Director, Life Technologies India Pvt Ltd
Ph: +91-09810521400
rajan@lifetechindia.com or rajan@atzlabs.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow